Andrew Xilas - 31 May 2024 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: SVP and GM, Dental
Issuer ticker: STE
Reported as of: 31 May 2024
Net transaction value: -$27,637
SEC form: 4
Accepted by SEC: 04 Jun 2024, 16:31:43 UTC
Prior SEC filing: 06 Dec 2023
Source filing: View source filing
Reporting owner signature: /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney

Key filing fact

Andrew Xilas filed Form 4 for STERIS plc (STE) on 04 Jun 2024.

Key facts

This page summarizes Andrew Xilas's Form 4 filing for STERIS plc (STE).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Jun 2024, 16:31.

Change

Previous filing in this sequence was filed on 06 Dec 2023.
Current net transaction value: -$27,637.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Tax liability

Transaction value: $27,637
Shares: -124
Change %: -1.9%
Price: $222.88
Shares after: 6,347
Date: 31 May 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Andrew Xilas is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Explanation of responses 2 footnotes

Footnote F1

124 shares were withheld from the 426 restricted shares that vested on May 31, 2024. These 124 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 426 ordinary shares were awarded to Mr. Xilas on May 31, 2023. These vested shares were valued at the NYSE closing market price on May 31, 2024.

Footnote F2

As of May 31, 2024, 2,486 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 3, 2024; 289 on October 1, 2024; 426 on June 2, 2025, 352 on June 2, 2025; 289 on October 1, 2025, 426 on June 1, 2026 and 352 on June 2, 2026.